Rights of Data Subjects Participating in the Study Sample Clauses

Rights of Data Subjects Participating in the Study. Institution and Pfizer agree that, as between them, Institution is best able to manage requests from Study Subjects for access, amendment, Transfer, restriction, or deletion of Personal Data. In the event that Pfizer and/or CRO receive a request from a Study Subject for such access, amendment, Transfer, restriction, or deletion, Pfizer or CRO will forward the request to Institution. Institution will respond to Study Subjects’ requests for access, amendment, Transfer, restriction, or deletion of Personal Data in accordance with Applicable Law, the Agreement, and any other instructions provided by Pfizer. Institution acknowledges that in order to maintain the integrity of Study results, the ability to amend, restrict, or delete Personal Data may be limited, in accordance with Applicable Law. Pfizer acknowledges that Study Subjects may withdraw their informed consent to Study participation 8. Práva subjektů údajů účastnících se studie. Zdravotnické zařízení a společnost Pfizer souhlasí se skutečností, že zdravotnické zařízení je z nich nejlépe schopno řešit žádosti pacientů ve studii o přístup k osobním údajům, jejich změnu, přenos, omezení nebo odstranění. Jestliže společnost Pfizer a/nebo CRO obdrží od pacienta ve studii takovou žádost o přístup k osobním údajům, jejich změnu, převod, omezení nebo odstranění, společnost Pfizer nebo CRO předá žádost zdravotnickému zařízení. Zdravotnické zařízení bude reagovat na žádosti pacientů ve studii o přístup k osobním údajům, jejich změnu, přenos, omezení nebo odstranění v souladu s platnými zákony, smlouvou a jakýmikoli dalšími pokyny poskytnutými společností Pfizer. Zdravotnické zařízení bere na vědomí, že za účelem zachování integrity výsledků studie může být možnost upravovat, omezovat nebo odstraňovat osobní údaje v souladu s platnými zákony omezena. Společnost Pfizer bere na and their consent to Processing of Personal Data at any time. vědomí, že pacienti ve studii mohou svůj informovaný souhlas s účastí ve studii a svůj souhlas se zpracováním osobních údajů kdykoli odvolat.
AutoNDA by SimpleDocs
Rights of Data Subjects Participating in the Study. The Parties and Pfizer agree that, as between them, Institution and Principal Investigator are best able to manage requests from Study subjects for access, amendment, Transfer, restriction, or deletion of Personal Data. In the event that Pfizer or CRO receives a request from a Study subject for such access, amendment, Transfer, restriction, or deletion, Pfizer or CRO shall forward the request to Institution and Principal Investigator. Institution and Principal Investigator shall respond to Study subjects’ requests for access, amendment, Transfer, restriction, or deletion of Personal Data in accordance with Applicable Law, the Agreement, and any other instructions provided by Pfizer or CRO. Institution and Principal Investigator acknowledge that in order to maintain the integrity of Study results, the ability to amend, restrict, or delete Personal Data may be limited, in accordance with Applicable Law. Pfizer acknowledges that Study subjects may withdraw their informed consent to Study participation and their consent to Processing of Personal Data at any time. 8. Práva subjektů údajů účastnících se Studie. Strany a společnost Pfizer souhlasí s tím, že Zdravotnické zařízení a Hlavní zkoušející jsou nejlépe schopni spravovat požadavky subjektů hodnocení na přístup, změnu, Přenos, omezení nebo odstranění Osobních údajů. V případě, že společnost Pfizer nebo CRO obdrží žádost od subjektu hodnocení o takový přístup, změnu, Přenos, omezení nebo odstranění, společnost Pfizer nebo CRO předá požadavek Zdravotnickému zařízení a Hlavnímu zkoušejícímu. Zdravotnické zařízení a Hlavní zkoušející musí reagovat na žádosti subjektů hodnocení o přístup, změnu, Přenos, omezení nebo výmaz Osobních údajů v souladu s Platnými právními předpisy, Smlouvou a jakýmikoliv dalšími pokyny poskytnutými společností Pfizer nebo CRO. Zdravotnické zařízení a Hlavní zkoušející berou na vědomí, že v zájmu zachování integrity výsledků Studie, může být omezena možnost změnit, omezit, nebo odstranit Osobní údaje v souladu s Platnými právními předpisy. Společnost Pfizer bere na vědomí, že subjekty hodnocení mohou kdykoliv odvolat svůj informovaný souhlas s účastí ve Studii a souhlas se Zpracováváním Osobních údajů.
Rights of Data Subjects Participating in the Study. Institution and Pfizer agree that, as between them, Institution is best able to manage requests from Study Subjects for access, amendment, Transfer, restriction, or deletion of Personal Data. In the event that Pfizer and/or CRO receive a request from a Study Subject for such access, amendment, Transfer, restriction, or deletion, Pfizer or CRO will forward the request to Institution. Institution will respond to Study Subjects’ requests for access, amendment, Transfer, restriction, or deletion of Personal Data in accordance with Applicable Law, the Agreement, and any other instructions provided by Pfizer. Institution acknowledges that in order to maintain the integrity of Study results, the ability to amend, restrict, or delete Personal Data may be limited, in accordance with Applicable Law. Pfizer acknowledges that Study Subjects may withdraw their informed consent to Study participation and their consent to Processing of Personal Data at any time.
Rights of Data Subjects Participating in the Study. Center and Sponsor agree that, as between them, Center is best able to manage data protection requests from trial subjects and will will respond to trial subjects’ requests in accordance with applicable law. Center will promptly notify Sponsor at XXX of any withdrawal of any consent to data processing provided by a trial subject.
Rights of Data Subjects Participating in the Study. Center and Sponsor agree that, as between them, Center is best able to manage data protection requests from Clinical Trial subjects and will will respond to trial subjects’ requests in accordance with applicable law. Center will promptly notify Sponsor of any withdrawal of any consent to data processing provided by a Clinical Trial subject. Príloha č. 3 Medzinárodné protikorupčné pravidlá Appendix 3 International Anti-Bribery & Corruption Principles PFIZER INTERNATIONAL ANTI-BRIBERY AND ANTI-CORRUPTION BUSINESS PRINCIPLES Pfizer has a long-standing policy forbidding bribery and corruption in the conduct of our business in the United States or abroad. Pfizer is committed to performing business with integrity, and acting ethically and legally in accordance with all applicable laws and regulations. We expect the same commitment from the consultants, agents, representatives or other companies and individuals acting on our behalf (“Business Associates”), as well as those acting on behalf of Business Associates (e.g., subcontractors), in connection with work for Pfizer. Bribery of Government Officials
Rights of Data Subjects Participating in the Study. Center and Sponsor agree that, as between them, Center is best able to manage data protection requests from trial subjects and will will respond to trial subjects’ requests in accordance with applicable law. Center will promptly notify Sponsor at Xxxxxxxx_xxxxxxxxxxx@xxxxxx.xxx of any withdrawal of any consent to data processing provided by a trial subject. 1.4 Práva dotyčných osob účastnících se Klinického zkoušení. Centrum a Zadavatel se dohodli, že Centrum bude vyřizovat žádosti na ochranu údajů od subjektů hodnocení a bude na žádosti subjektů hodnoceníreagovat v souladu s platnými zákony. Centrum neprodleně informuje Zadavatele na adrese Xxxxxxxx_xxxxxxxxxxx@xxxxxx.xxx o jakémkoli odvolání jakéhokoli souhlasu se zpracováním údajů poskytnutým subjektem zkoušení.
Rights of Data Subjects Participating in the Study. Center and Sponsor agree that, as tom, že spomedzi nich Centrum dokáže najlepšie spracovávať požiadavky zo strany subjektov Klinického skúšania týkajúce sa ochrany osobných údajov a bude odpovedať na požiadavky zo strany subjektov skúšania v súlade s príslušným zákonom. Centrum bezodkladne oznámi Zadávateľovi každé odvolanie súhlasu so spracovávaním osobných údajov zo strany subjektu Klinického skúšania. between them, Center is best able to manage data protection requests from Clinical Trial subjects and will will respond to trial subjects’ requests in accordance with applicable law. Center will promptly notify Sponsor of any withdrawal of any consent to data processing provided by a Clinical Trial subject.
AutoNDA by SimpleDocs
Rights of Data Subjects Participating in the Study. Contractor and Pfizer agree that, as between them, Contractor is best able to manage requests from Study Subjects for access, amendment, Transfer, restriction, or deletion of Personal Data. In the event that Pfizer receives a request from a Study Subject for such access, amendment, Transfer, restriction, or deletion, Pfizer will forward the request to Contractor. Contractor will respond to Study Subjects’ requests for access, amendment, Transfer, restriction, or deletion of Personal Data in accordance with Applicable Law, the Agreement, and any other instructions provided by Pfizer. Contractor acknowledges that in order to maintain the integrity of Study results, the ability to amend, restrict, or delete Personal Data may be limited, in accordance with Applicable Law. Pfizer acknowledges that Study Subjects may withdraw their informed consent to Study participation and their consent to Processing of Personal Data at any time.
Rights of Data Subjects Participating in the Study. Institution and XXX agree that, as between them, Institution is best able to manage requests from Study Subjects for access, amendment, Transfer, restriction, or deletion of Personal Data. In the event that XXX and/or CRO receive a request from a Study Subject for such access, amendment, Transfer, restriction, or deletion, XXX or CRO will forward the request to Institution. Institution will respond to Study Subjects’ requests for access, amendment, Transfer, restriction, or deletion of Personal Data in accordance with Applicable Law, the Agreement, and any other instructions provided by XXX. Institution acknowledges that in order to maintain the integrity of Study results, the ability to amend, restrict, or delete Personal Data may be limited, in accordance with Applicable Law. XXX acknowledges that Study Subjects may withdraw their informed consent to Study participation and their consent to Processing of Personal Data at any time.
Rights of Data Subjects Participating in the Study. The Institution and Sponsor agree that, as between them, Institution is best able to manage requests from Study subjects to exercise their rights under Data Protection Laws in respect of their Personal Data Processed in the context of the Study.
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!